Skip to main content
Erschienen in: Infection 5/2011

01.10.2011 | Brief Report

Staphylococcus simulans as an authentic pathogenic agent of osteoarticular infections

verfasst von: M. Mallet, C. Loiez, H. Melliez, Y. Yazdanpanah, E. Senneville, X. Lemaire

Erschienen in: Infection | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To evaluate the role of Staphylococcus simulans in bone and joint infections (BJI) and determine their main characteristics.

Methods

A search of the database of the microbiology laboratories of Lille hospital and Tourcoing hospital was performed. Only results from blood, bone, and orthopedic device cultures were taken into account for hospitalized patients between January 2004 and January 2009. We considered cases in which S. simulans was the only bacteria isolated in all of the patients’ biological samples with clinical and laboratory signs of infection. For patients with complete medical records, we recorded the clinical and epidemiological data.

Results

Six cases of BJI due to S. simulans were recorded, with five cases related to orthopedic devices infections. Three patients lived in rural areas. In four out of six patients, S. simulans was isolated in intraoperative biopsy material. In one patient, S. simulans grew in synovial fluid and in another in blood cultures only. The latter patient had a spondylodiscitis, and chronic foot ulcers due to gout disease were suspected to be the origin of the infection. All patients were healed after a mean follow up of 9 ± 3 months. Orthopedic devices were removed in four of the five patients concerned. The combination of rifampicin plus levofloxacin was used in four patients.

Conclusion

The present data suggest that, even though S. simulans remains rarely observed in clinical pathology, its role in osteoarticular infections, especially in the case of infected orthopedic devices, is not exceptional. As for the antibiotic treatment, the combination of rifampicin and levofloxacin seems to be an effective strategy according to our clinical results.
Literatur
1.
Zurück zum Zitat Males BM, Bartholomew WR, Amsterdam D. Staphylococcus simulans septicemia in a patient with chronic osteomyelitis and pyarthrosis. J Clin Microbiol. 1985;21:255–7.PubMed Males BM, Bartholomew WR, Amsterdam D. Staphylococcus simulans septicemia in a patient with chronic osteomyelitis and pyarthrosis. J Clin Microbiol. 1985;21:255–7.PubMed
2.
Zurück zum Zitat Razonable RR, Lewallen DG, Patel R, Osmon DR. Vertebral osteomyelitis and prosthetic joint infection due to Staphylococcus simulans. Mayo Clin Proc. 2001;76:1067–70.PubMedCrossRef Razonable RR, Lewallen DG, Patel R, Osmon DR. Vertebral osteomyelitis and prosthetic joint infection due to Staphylococcus simulans. Mayo Clin Proc. 2001;76:1067–70.PubMedCrossRef
3.
Zurück zum Zitat Sturgess I, Martin FC, Eykyn S. Pubic osteomyelitis caused by Staphylococcus simulans. Postgrad Med J. 1993;69:927–9.PubMedCrossRef Sturgess I, Martin FC, Eykyn S. Pubic osteomyelitis caused by Staphylococcus simulans. Postgrad Med J. 1993;69:927–9.PubMedCrossRef
4.
Zurück zum Zitat Vallianou N, Evangelopoulos A, Makri P, Zacharias G, Stefanitsi P, Karachalios A, et al. Vertebral osteomyelitis and native valve endocarditis due to Staphylococcus simulans: a case report. J Med Case Rep. 2008;2:183.CrossRef Vallianou N, Evangelopoulos A, Makri P, Zacharias G, Stefanitsi P, Karachalios A, et al. Vertebral osteomyelitis and native valve endocarditis due to Staphylococcus simulans: a case report. J Med Case Rep. 2008;2:183.CrossRef
5.
Zurück zum Zitat Senneville E, Savage C, Nallet I, Yazdanpanah Y, Giraud F, Migaud H, et al. Improved aero–anaerobe recovery from infected prosthetic joint samples taken from 72 patients and collected intraoperatively in Rosenow’s broth. Acta Orthop. 2006;77:120–4.PubMedCrossRef Senneville E, Savage C, Nallet I, Yazdanpanah Y, Giraud F, Migaud H, et al. Improved aero–anaerobe recovery from infected prosthetic joint samples taken from 72 patients and collected intraoperatively in Rosenow’s broth. Acta Orthop. 2006;77:120–4.PubMedCrossRef
6.
Zurück zum Zitat Thorberg BM, Danielsson-Tham ML, Emanuelson U, Persson Waller K. Bovine subclinical mastitis caused by different types of coagulase-negative staphylococci. J Dairy Sci. 2009;92:4962–70.PubMedCrossRef Thorberg BM, Danielsson-Tham ML, Emanuelson U, Persson Waller K. Bovine subclinical mastitis caused by different types of coagulase-negative staphylococci. J Dairy Sci. 2009;92:4962–70.PubMedCrossRef
7.
Zurück zum Zitat Penna B, Varges R, Medeiros L, Martins GM, Martins RR, Lilenbaum W. Species distribution and antimicrobial susceptibility of staphylococci isolated from canine otitis externa. Vet Dermatol. 2010;21:292–6.PubMedCrossRef Penna B, Varges R, Medeiros L, Martins GM, Martins RR, Lilenbaum W. Species distribution and antimicrobial susceptibility of staphylococci isolated from canine otitis externa. Vet Dermatol. 2010;21:292–6.PubMedCrossRef
8.
Zurück zum Zitat Lilenbaum W, Esteves AL, Souza GN. Prevalence and antimicrobial susceptibility of staphylococci isolated from saliva of clinically normal cats. Lett Appl Microbiol. 1999;28:448–52.PubMedCrossRef Lilenbaum W, Esteves AL, Souza GN. Prevalence and antimicrobial susceptibility of staphylococci isolated from saliva of clinically normal cats. Lett Appl Microbiol. 1999;28:448–52.PubMedCrossRef
9.
Zurück zum Zitat Kloos WE, Barnerman TL. Staphylococcus and Micrococcus. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. 7th ed. ASM Press: Washington; 1999. Kloos WE, Barnerman TL. Staphylococcus and Micrococcus. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. 7th ed. ASM Press: Washington; 1999.
10.
Zurück zum Zitat McCarthy JS, Stanley PA, Mayall B. A case of Staphylococcus simulans endocarditis affecting a native heart valve. J Infect. 1991;22:211–2.PubMedCrossRef McCarthy JS, Stanley PA, Mayall B. A case of Staphylococcus simulans endocarditis affecting a native heart valve. J Infect. 1991;22:211–2.PubMedCrossRef
11.
Zurück zum Zitat Ohshima Y, Schumacher-Perdreau F, Peters G, Pulverer G. The role of capsule as a barrier to bacteriophage adsorption in an encapsulated Staphylococcus simulans strain. Med Microbiol Immunol. 1988;177:229–33.PubMed Ohshima Y, Schumacher-Perdreau F, Peters G, Pulverer G. The role of capsule as a barrier to bacteriophage adsorption in an encapsulated Staphylococcus simulans strain. Med Microbiol Immunol. 1988;177:229–33.PubMed
12.
Zurück zum Zitat Dupont C, Sivadon-Tardy V, Bille E, Dauphin B, Beretti JL, Alvarez AS, et al. Identification of clinical coagulase-negative staphylococci, isolated in microbiology laboratories, by matrix-assisted laser desorption/ionization-time of flight mass spectrometry and two automated systems. Clin Microbiol Infect. 2010;16:998–1004.PubMed Dupont C, Sivadon-Tardy V, Bille E, Dauphin B, Beretti JL, Alvarez AS, et al. Identification of clinical coagulase-negative staphylococci, isolated in microbiology laboratories, by matrix-assisted laser desorption/ionization-time of flight mass spectrometry and two automated systems. Clin Microbiol Infect. 2010;16:998–1004.PubMed
13.
Zurück zum Zitat Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004;351:1645–54.PubMedCrossRef Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004;351:1645–54.PubMedCrossRef
14.
Zurück zum Zitat Bindal M, Krabak B. Acute bacterial sacroiliitis in an adult: a case report and review of the literature. Arch Phys Med Rehabil. 2007;88:1357–9.PubMedCrossRef Bindal M, Krabak B. Acute bacterial sacroiliitis in an adult: a case report and review of the literature. Arch Phys Med Rehabil. 2007;88:1357–9.PubMedCrossRef
15.
Zurück zum Zitat El Samad Y, Havet E, Bentayeb H, Olory B, Canarelli B, Lardanchet JF, et al. Treatment of osteoarticular infections with clindamycin in adults. Med Mal Infect. 2008;38:465–70.PubMedCrossRef El Samad Y, Havet E, Bentayeb H, Olory B, Canarelli B, Lardanchet JF, et al. Treatment of osteoarticular infections with clindamycin in adults. Med Mal Infect. 2008;38:465–70.PubMedCrossRef
Metadaten
Titel
Staphylococcus simulans as an authentic pathogenic agent of osteoarticular infections
verfasst von
M. Mallet
C. Loiez
H. Melliez
Y. Yazdanpanah
E. Senneville
X. Lemaire
Publikationsdatum
01.10.2011
Verlag
Springer-Verlag
Erschienen in
Infection / Ausgabe 5/2011
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-011-0173-x

Weitere Artikel der Ausgabe 5/2011

Infection 5/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gut molekulare Response, aber seltener ernste Nebenwirkungen.

Hereditäres Angioödem: Tablette könnte Akuttherapie erleichtern

05.06.2024 Hereditäres Angioödem Nachrichten

Medikamente zur Bedarfstherapie bei hereditärem Angioödem sind bisher nur als Injektionen und Infusionen verfügbar. Der Arzneistoff Sebetralstat kann oral verabreicht werden und liefert vielversprechende Daten.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.